placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Wound Closure / Topical Skin Adhesives / flexifuze™* Tissue Adhesive

You are entering HCP content only

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

Overview

Indicated for the closure of skin wounds, including laparoscopic incisions and trauma-induced lacerations. May be used in conjunction with deep dermal stitches.

See How It Works

Watch Video
Order Information
Code Description Shipper Case Quantity
CM001 INDERMIL® flexifuze™* Tissue Adhesive 12

Order Information

Clinical Evidence

  • Flexible1 - Has been designed to be a flexible adhesive when cured to maintain that flexibility over time1
  • Microbial Barrier2 - In vitro studies have shown that it will stay in place for 5-8 days acting as an effective physical barrier to microbial penetration as long as the adhesive film remains intact3
  • Dye free formulation - No Discoloration of Wound Sites4
  • Allows Patient to Shower Daily5 - After 1 hour and up to 5 to 8 days
  • High Wound Closure Strength6

Resources

  • * Property of Connexicon Medical Ltd.
  • † Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties *Bench test results may not necessarily be indicative of clinical performance
  • 1. Purdue Pascoe VOC report, report # J906 (slide 27) b. Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties, as reported by visual examination of product application on samples subject to repeated cyclic mechanical constraints.
  • 2. Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015
  • 3. Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus,Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus
  • 4. Scar Tattooing following the Use of Tissue Adhesive Swan, Marc C. M.R.C.S.; Descamps, Marjanne J. L. M.R.C.S.; Broadhurst, Andrew F.R.C.S.Nurse Pract 2001;13:10-12
  • 5. Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015 *Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus, Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus
  • 6. Wound Closure Strength testing was carried out in accordance with ASTM F2458-05. Bench test results may not necessarily be indicative of clinical performance
Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2025 Medtronic